Elevance Health (ELV) Short-Term Debt issuances (2016 - 2025)
Elevance Health (ELV) has disclosed Short-Term Debt issuances for 17 consecutive years, with $1.2 billion as the latest value for Q4 2025.
- On a quarterly basis, Short-Term Debt issuances rose 365.02% to $1.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 billion, a 305.64% increase, with the full-year FY2025 number at $1.3 billion, up 305.64% from a year prior.
- Short-Term Debt issuances was $1.2 billion for Q4 2025 at Elevance Health, up from -$554.0 million in the prior quarter.
- In the past five years, Short-Term Debt issuances ranged from a high of $1.4 billion in Q1 2024 to a low of -$1.8 billion in Q2 2024.
- A 5-year average of $70.8 million and a median of $288.0 million in 2022 define the central range for Short-Term Debt issuances.
- Peak YoY movement for Short-Term Debt issuances: tumbled 386.46% in 2023, then skyrocketed 1434.78% in 2024.
- Elevance Health's Short-Term Debt issuances stood at -$551.0 million in 2021, then soared by 201.27% to $558.0 million in 2022, then increased by 14.16% to $637.0 million in 2023, then tumbled by 173.16% to -$466.0 million in 2024, then skyrocketed by 365.02% to $1.2 billion in 2025.
- Per Business Quant, the three most recent readings for ELV's Short-Term Debt issuances are $1.2 billion (Q4 2025), -$554.0 million (Q3 2025), and $631.0 million (Q2 2025).